Benzinga's Top Ratings Upgrades, Downgrades For November 29, 2021

 

Upgrades

  • According to Odeon Capital, the prior rating for Wells Fargo & Co WFC was changed from Hold to Buy. In the third quarter, Wells Fargo showed an EPS of $1.17, compared to $0.42 from the year-ago quarter. The current stock performance of Wells Fargo shows a 52-week-high of $52.56 and a 52-week-low of $27.28. Moreover, at the end of the last trading period, the closing price was at $48.43.
  • For HeadHunter Group PLC HHR, UBS upgraded the previous rating of Neutral to Buy. In the third quarter, HeadHunter Group showed an EPS of $0.54, compared to $0.20 from the year-ago quarter. The current stock performance of HeadHunter Group shows a 52-week-high of $68.18 and a 52-week-low of $24.25. Moreover, at the end of the last trading period, the closing price was at $51.70.
  • According to Stephens & Co., the prior rating for Truist Financial Corp TFC was changed from Equal-Weight to Overweight. Truist Financial earned $1.42 in the third quarter, compared to $0.97 in the year-ago quarter. At the moment, the stock has a 52-week-high of $65.42 and a 52-week-low of $45.44. Truist Financial closed at $60.08 at the end of the last trading period.
  • According to Citigroup, the prior rating for TJX Companies Inc TJX was changed from Neutral to Buy. TJX Companies earned $0.84 in the third quarter, compared to $0.71 in the year-ago quarter. At the moment, the stock has a 52-week-high of $76.94 and a 52-week-low of $61.15. TJX Companies closed at $69.36 at the end of the last trading period.
  • Citigroup upgraded the previous rating for Burlington Stores Inc BURL from Neutral to Buy. Burlington Stores earned $1.36 in the third quarter, compared to $0.29 in the year-ago quarter. At the moment, the stock has a 52-week-high of $357.34 and a 52-week-low of $217.38. Burlington Stores closed at $283.85 at the end of the last trading period.
  • According to Truist Securities, the prior rating for MGP Ingredients Inc MGPI was changed from Hold to Buy. In the third quarter, MGP Ingredients showed an EPS of $1.09, compared to $0.61 from the year-ago quarter. The stock has a 52-week-high of $79.52 and a 52-week-low of $42.42. At the end of the last trading period, MGP Ingredients closed at $73.51.
  • For Copa Holdings SA CPA, Raymond James upgraded the previous rating of Outperform to Strong Buy. For the third quarter, Copa Holdings had an EPS of $0.70, compared to year-ago quarter EPS of $2.86. At the moment, the stock has a 52-week-high of $94.91 and a 52-week-low of $64.66. Copa Holdings closed at $71.77 at the end of the last trading period.
  • Morgan Stanley upgraded the previous rating for Adagio Therapeutics Inc ADGI from Equal-Weight to Overweight.
  • For Surgery Partners Inc SGRY, Stifel upgraded the previous rating of Hold to Buy. For the third quarter, Surgery Partners had an EPS of $0.05, compared to year-ago quarter EPS of $0.53. At the moment, the stock has a 52-week-high of $69.58 and a 52-week-low of $24.20. Surgery Partners closed at $43.74 at the end of the last trading period.
  • For argenx SE ARGX, Piper Sandler upgraded the previous rating of Neutral to Overweight. In the third quarter, argenx showed an EPS of $4.40, compared to $3.96 from the year-ago quarter. The current stock performance of argenx shows a 52-week-high of $382.15 and a 52-week-low of $248.21. Moreover, at the end of the last trading period, the closing price was at $276.10.
  • Raymond James upgraded the previous rating for Bumble Inc BMBL from Market Perform to Outperform. For the third quarter, Bumble had an EPS of $0.06, compared to year-ago quarter EPS of $0.01. The current stock performance of Bumble shows a 52-week-high of $84.80 and a 52-week-low of $33.29. Moreover, at the end of the last trading period, the closing price was at $33.83.
  • For Hyatt Hotels Corp H, JP Morgan upgraded the previous rating of Neutral to Overweight. In the third quarter, Hyatt Hotels showed an EPS of $2.31, compared to $1.48 from the year-ago quarter. The current stock performance of Hyatt Hotels shows a 52-week-high of $94.92 and a 52-week-low of $65.44. Moreover, at the end of the last trading period, the closing price was at $78.13.

See all analyst ratings upgrades.

 

Downgrades

  • For Apellis Pharmaceuticals Inc APLS, Roth Capital downgraded the previous rating of Buy to Neutral. Apellis Pharmaceuticals earned $1.57 in the third quarter, compared to $1.79 in the year-ago quarter. The stock has a 52-week-high of $73.00 and a 52-week-low of $27.50. At the end of the last trading period, Apellis Pharmaceuticals closed at $43.54.
  • For Jumia Technologies AG JMIA, Morgan Stanley downgraded the previous rating of Equal-Weight to Underweight. At the moment, the stock has a 52-week-high of $69.89 and a 52-week-low of $11.96. Jumia Technologies closed at $13.64 at the end of the last trading period.
  • For Saia Inc SAIA, Deutsche Bank downgraded the previous rating of Buy to Hold. In the third quarter, Saia showed an EPS of $2.86, compared to $1.56 from the year-ago quarter. The stock has a 52-week-high of $365.50 and a 52-week-low of $171.00. At the end of the last trading period, Saia closed at $335.83.
  • For U.S. Bancorp USB, Stephens & Co. downgraded the previous rating of Overweight to Equal-Weight. In the third quarter, U.S. Bancorp showed an EPS of $1.30, compared to $0.99 from the year-ago quarter. The current stock performance of U.S. Bancorp shows a 52-week-high of $63.01 and a 52-week-low of $42.47. Moreover, at the end of the last trading period, the closing price was at $57.50.
  • According to Deutsche Bank, the prior rating for Canadian Pacific Railway Ltd CP was changed from Buy to Hold. For the third quarter, Canadian Pacific Railway had an EPS of $0.70, compared to year-ago quarter EPS of $0.62. At the moment, the stock has a 52-week-high of $404.43 and a 52-week-low of $64.37. Canadian Pacific Railway closed at $71.31 at the end of the last trading period.
  • Deutsche Bank downgraded the previous rating for United Parcel Service Inc UPS from Buy to Hold. For the third quarter, United Parcel Service had an EPS of $2.71, compared to year-ago quarter EPS of $2.28. The current stock performance of United Parcel Service shows a 52-week-high of $220.24 and a 52-week-low of $154.76. Moreover, at the end of the last trading period, the closing price was at $205.30.
  • For Beacon Roofing Supply Inc BECN, Truist Securities downgraded the previous rating of Buy to Hold. For the fourth quarter, Beacon Roofing Supply had an EPS of $1.78, compared to year-ago quarter EPS of $1.30. The current stock performance of Beacon Roofing Supply shows a 52-week-high of $60.93 and a 52-week-low of $35.86. Moreover, at the end of the last trading period, the closing price was at $53.77.
  • According to Wells Fargo, the prior rating for Greif Inc GEF was changed from Overweight to Equal-Weight. In the third quarter, Greif showed an EPS of $1.93, compared to $0.85 from the year-ago quarter. The current stock performance of Greif shows a 52-week-high of $72.00 and a 52-week-low of $44.16. Moreover, at the end of the last trading period, the closing price was at $67.66.
  • According to Citigroup, the prior rating for Merck & Co Inc MRK was changed from Buy to Neutral. For the third quarter, Merck & Co had an EPS of $1.75, compared to year-ago quarter EPS of $1.74. The current stock performance of Merck & Co shows a 52-week-high of $91.40 and a 52-week-low of $15.32. Moreover, at the end of the last trading period, the closing price was at $79.16.
  • Piper Sandler downgraded the previous rating for Hudson Pacific Properties Inc HPP from Overweight to Neutral. For the third quarter, Hudson Pacific Properties had an EPS of $0.50, compared to year-ago quarter EPS of $0.43. The current stock performance of Hudson Pacific Properties shows a 52-week-high of $30.35 and a 52-week-low of $22.75. Moreover, at the end of the last trading period, the closing price was at $25.33.
  • According to Jefferies, the prior rating for CyrusOne Inc CONE was changed from Buy to Hold. In the third quarter, CyrusOne showed an EPS of $1.02, compared to $0.96 from the year-ago quarter. The current stock performance of CyrusOne shows a 52-week-high of $89.92 and a 52-week-low of $61.64. Moreover, at the end of the last trading period, the closing price was at $89.24.

See all analyst ratings downgrades.

 

Initiations

  • EF Hutton initiated coverage on ComSovereign Holding Corp COMS with a Buy rating. The price target for ComSovereign Holding is set to $2.10. At the moment, the stock has a 52-week-high of $5.78 and a 52-week-low of $1.01. ComSovereign Holding closed at $1.15 at the end of the last trading period.
  • William Blair initiated coverage on Allbirds Inc BIRD with an Outperform rating.
  • With an Overweight rating, Stephens & Co. initiated coverage on Cadre Holdings Inc CDRE. The price target seems to have been set at $23.00 for Cadre Hldgs.
  • With an Outperform rating, Oppenheimer initiated coverage on Nerdwallet Inc NRDS. The price target seems to have been set at $30.00 for Nerdwallet.
  • Maxim Group initiated coverage on Worksport Ltd WKSP with a Buy rating. The price target for Worksport is set to $8.00. In the third quarter, Worksport showed an EPS of $0.15, compared to $0.21 from the year-ago quarter. The current stock performance of Worksport shows a 52-week-high of $9.09 and a 52-week-low of $0.12. Moreover, at the end of the last trading period, the closing price was at $3.86.
  • With a Buy rating, Maxim Group initiated coverage on Acurx Pharmaceuticals Inc ACXP. The price target seems to have been set at $12.00 for Acurx Pharmaceuticals. For the third quarter, Acurx Pharmaceuticals had an EPS of $0.46, compared to year-ago quarter EPS of $0.21. At the moment, the stock has a 52-week-high of $8.74 and a 52-week-low of $3.71. Acurx Pharmaceuticals closed at $4.89 at the end of the last trading period.
  • With a Equal-Weight rating, Morgan Stanley initiated coverage on Nerdwallet Inc NRDS. The price target seems to have been set at $24.00 for Nerdwallet.
  • Morgan Stanley initiated coverage on Arhaus Inc ARHS with a Equal-Weight rating. The price target for Arhaus is set to $12.00.
  • For Evotec SE EVO, Cowen & Co. initiated coverage, by setting the current rating at Outperform.
  • With a Hold rating, Stifel initiated coverage on Cadre Holdings Inc CDRE. The price target seems to have been set at $20.00 for Cadre Hldgs.
  • With an Outperform rating, JMP Securities initiated coverage on iBio Inc IBIO. The price target seems to have been set at $1.50 for iBio. In the first quarter, iBio showed an EPS of $0.04, compared to $0.05 from the year-ago quarter. At the moment, the stock has a 52-week-high of $2.83 and a 52-week-low of $0.56. iBio closed at $0.66 at the end of the last trading period.
  • Truist Securities initiated coverage on Nerdwallet Inc NRDS with a Buy rating. The price target for Nerdwallet is set to $30.00.
  • With a Buy rating, BTIG initiated coverage on Freeline Therapeutics Holdings PLC FRLN. The price target seems to have been set at $10.00 for Freeline Therapeutics. At the moment, the stock has a 52-week-high of $18.88 and a 52-week-low of $2.15. Freeline Therapeutics closed at $2.31 at the end of the last trading period.
  • With a Buy rating, BTIG initiated coverage on MDxHealth SA MDXH. The price target seems to have been set at $15.00 for MDxHealth.
  • Atlantic Equities initiated coverage on Allegion PLC ALLE with an Overweight rating. The price target for Allegion is set to $155.00. Allegion earned $1.56 in the third quarter, compared to $1.67 in the year-ago quarter. The current stock performance of Allegion shows a 52-week-high of $148.69 and a 52-week-low of $106.52. Moreover, at the end of the last trading period, the closing price was at $129.37.
  • B. Riley Securities initiated coverage on Cadre Holdings Inc CDRE with a Buy rating. The price target for Cadre Hldgs is set to $26.00.
  • Needham initiated coverage on Inozyme Pharma Inc INZY with a Buy rating. The price target for Inozyme Pharma is set to $23.00. In the third quarter, Inozyme Pharma showed an EPS of $0.60, compared to $1.55 from the year-ago quarter. The current stock performance of Inozyme Pharma shows a 52-week-high of $29.46 and a 52-week-low of $7.66. Moreover, at the end of the last trading period, the closing price was at $8.00.
  • With a Neutral rating, Piper Sandler initiated coverage on Affirm Holdings Inc AFRM. The price target seems to have been set at $127.00 for Affirm Holdings. The stock has a 52-week-high of $176.65 and a 52-week-low of $46.50. At the end of the last trading period, Affirm Holdings closed at $136.98.
  • With a Neutral rating, Piper Sandler initiated coverage on Synchrony Financial SYF. The price target seems to have been set at $52.00 for Synchrony Finl. Synchrony Finl earned $2.00 in the third quarter, compared to $0.63 in the year-ago quarter. The current stock performance of Synchrony Finl shows a 52-week-high of $52.49 and a 52-week-low of $30.43. Moreover, at the end of the last trading period, the closing price was at $47.68.

See all analyst ratings initiations.

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
date
ticker
name
Price Target
Upside/Downside
Recommendation
Firm
Posted In: UpgradesDowngradesInitiationIntraday UpdateAnalyst RatingsBZI-Ratings
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!